Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T-cell epitope peptide vaccines.

Sherine F Elsawa1, David A Rodeberg, Esteban Celis

  • 1Department of Immunology, Mayo Clinic, Rochester, MN, USA. elsawa.sherine@mayo.edu

Expert Review of Vaccines
|October 16, 2004
PubMed
Summary

Peptide-based vaccines show promise for cancer treatment by stimulating T-cells. These vaccines target tumor antigens, offering a viable immunotherapy strategy to enhance antitumor T-lymphocyte responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of the ATR-CHK1 signaling pathway sensitizes MCPyV-positive Merkel cell carcinoma to gemcitabine.

BMC cancer·2026
Same author

Radiation Therapy Dose Escalation Failed to Improve Local Control for Intermediate-Risk Rhabdomyosarcoma on ARST1431: A Report From the Children's Oncology Group.

International journal of radiation oncology, biology, physics·2025
Same author

Differential Gene Expression in the Prefrontal Cortex and Hippocampus Following Long-Access Methamphetamine Self-Administration in Male Rats.

International journal of molecular sciences·2025
Same author

Rhabdomyosarcoma Surgical Update.

Pediatric blood & cancer·2025
Same author

GLI3 Is Required for M2 Macrophage Polarization and M2-Mediated Waldenström Macroglobulinemia Growth and Survival.

International journal of molecular sciences·2024
Same author

STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 Inhibition.

Molecular cancer therapeutics·2024

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • T-cell immunotherapy is a significant advancement in cancer treatment.
  • Identifying tumor antigens is crucial for developing effective cancer vaccines.
  • Peptide-based vaccines are advantageous due to their manufacturing ease and characterization.

Purpose of the Study:

  • To review the application of peptide-based vaccines in cancer therapy.
  • To explore the induction of antitumor T-lymphocyte responses by these vaccines.

Main Methods:

  • Review of existing literature on peptide-based cancer vaccines.
  • Analysis of T-cell responses to peptide vaccination strategies.

Main Results:

  • Peptide vaccines can effectively stimulate T-cells against tumors.
  • Successful generation of vaccines for various malignancies has been achieved.

Conclusions:

  • Peptide-based vaccines represent a promising approach for cancer immunotherapy.
  • Further research into optimizing peptide vaccines can enhance antitumor immunity.

Related Experiment Videos